.

  • Mike Ward

    Partner

  • Anita Choi

    Partner

  • Jean Nguyen

    Associate

  • Chris Gloria

    Associate

The antibody-based technology sector is one of the most dynamic in the biopharmaceutical industry. Cutting-edge innovation and discovery in antibody engineering and therapeutics as well as diagnostic and therapeutic advances in oncology and autoimmune therapies are poised to drive the market well over $300B in the next five years. Our Antibody patent practice offers clients unparalleled, comprehensive legal services to address the full life-cycle of issues shaping their businesses—helping them strengthen their IP and drive products to market. With a team that includes a sizeable group of USPTO-qualified attorneys and patent agents focused on antibody technologies, we have specific research experience in antibody and antibody-related science and we counsel on strategic planning and management of patent portfolios. We work with our clients to write successful patent applications for complex and novel antibodies with a goal of achieving the broadest protection possible, and in consideration of third-party patents as well as prospects for follow-on biologics. Our group also helps craft strategies to manage the intersection of IP with clinical trials development, international product approval strategy, and investigational new drug (IND) filings.

Morrison & Foerster has one of the most experienced and highly regarded pharmaceutical chemistry patent groups in the legal field. With 20+ Ph.D.s in fields such as chemistry, organic chemistry, medicinal chemistry, chemical biology, biochemistry, and chemical sciences and engineering—as well as many years of academic and industry research experience—we speak the language of our clients, appreciate the significance of their inventions, and effectively communicate the value of their innovations. Our team provides a full range of patent prosecution and strategic counseling services to startups and large pharmaceutical companies, and we tailor our approach to fit the business goals of each client. We take into account the entire life cycle of a drug, from pre-clinical research through commercial launch and follow-on formulations and indications, and design strategies to build meaningful patent protection around the world. Our experience drafting and filing robust patent applications that can withstand legal challenges by competitors provides the foundation on which we create a successful IP platform. We have extensive experience implementing global patent strategies to leverage the value of the global drug market.

Advanced Materials and Chemicals
In the advanced materials sector, Morrison & Foerster has represented manufacturers of acrylics, plastics, polymers, chemicals, industrial and special gases, and metal alloys. Our team prepares and prosecutes patents in areas including nanotechnology, polymer chemistry, and composite materials.

With more than 20 Ph.D. fields related to plant biology and microbiology, Morrison & Foerster’s Plant Intellectual Property team is the global leader in multinational IP diligence, protection, and enforcement related to seeds, plant varieties, gene editing, and agricultural products and equipment.

Our team oversees and coordinates the filing and maintenance of plant patent, plant breeders’ rights (PBRs), and plant-related trademark rights worldwide, and we have extensive experience preparing and obtaining utility patents for edited and transgenic plants expressing new traits, utility patents for new plant varieties, plant patents, and Plant Variety Protection (PVP) Certificates. We also advise and counsel clients on the handling of trademarks and variety denominations, and complex litigation matters.

In addition, we help our food and agtech clients in the U.S. and around the world secure patents on technologies related to artificial intelligence (AI), automation, biological pesticides, computer learning, data aggregation, drones, new plant traits, plant genomics, and user interfaces.

Life sciences data analytics are at the intersection of technology and healthcare, and our team advises clients on all legal aspects of this business, including patenting software and AI-related life sciences inventions, licensing of data, providing counsel on the steps to ensure data privacy and ethical use of data, and guiding clients through the FDA approval process for data-driven diagnostic assays and medical devices. Working at the forefront of both the life sciences and technology industries, we understand the challenges in patenting innovation in this evolving area and how to navigate the IP and regulatory hurdles in bringing new products to market.

Artificial Intelligence + Robotics
Morrison & Foerster provides sophisticated, full-service representation to a wide range of clients with companies that both develop and use cutting-edge, rapidly changing technology in the AI and robotics space. Our clients span the spectrum from startups to Silicon Valley industry leaders to global Fortune 100 power players. We work with clients from the earliest stages of development to protect innovations and obtain patent coverage for mechanical devices and robotics, artificial intelligence algorithms, virtual and augmented reality, drone technologies, automation, computer learning, graphics processing, and user interfaces.

.

  • Mike Ward

    Partner

  • Anita Choi

    Partner

  • Jean Nguyen

    Associate

  • Chris Gloria

    Associate

The antibody-based technology sector is one of the most dynamic in the biopharmaceutical industry. Cutting-edge innovation and discovery in antibody engineering and therapeutics as well as diagnostic and therapeutic advances in oncology and autoimmune therapies are poised to drive the market well over $300B in the next five years. Our Antibody patent practice offers clients unparalleled, comprehensive legal services to address the full life-cycle of issues shaping their businesses—helping them strengthen their IP and drive products to market. With a team that includes a sizeable group of USPTO-qualified attorneys and patent agents focused on antibody technologies, we have specific research experience in antibody and antibody-related science and we counsel on strategic planning and management of patent portfolios. We work with our clients to write successful patent applications for complex and novel antibodies with a goal of achieving the broadest protection possible, and in consideration of third-party patents as well as prospects for follow-on biologics. Our group also helps craft strategies to manage the intersection of IP with clinical trials development, international product approval strategy, and investigational new drug (IND) filings.

Morrison & Foerster has one of the most experienced and highly regarded pharmaceutical chemistry patent groups in the legal field. With 20+ Ph.D.s in fields such as chemistry, organic chemistry, medicinal chemistry, chemical biology, biochemistry, and chemical sciences and engineering—as well as many years of academic and industry research experience—we speak the language of our clients, appreciate the significance of their inventions, and effectively communicate the value of their innovations. Our team provides a full range of patent prosecution and strategic counseling services to startups and large pharmaceutical companies, and we tailor our approach to fit the business goals of each client. We take into account the entire life cycle of a drug, from pre-clinical research through commercial launch and follow-on formulations and indications, and design strategies to build meaningful patent protection around the world. Our experience drafting and filing robust patent applications that can withstand legal challenges by competitors provides the foundation on which we create a successful IP platform. We have extensive experience implementing global patent strategies to leverage the value of the global drug market.

Advanced Materials and Chemicals
In the advanced materials sector, Morrison & Foerster has represented manufacturers of acrylics, plastics, polymers, chemicals, industrial and special gases, and metal alloys. Our team prepares and prosecutes patents in areas including nanotechnology, polymer chemistry, and composite materials.

With more than 20 Ph.D. fields related to plant biology and microbiology, Morrison & Foerster’s Plant Intellectual Property team is the global leader in multinational IP diligence, protection, and enforcement related to seeds, plant varieties, gene editing, and agricultural products and equipment.

Our team oversees and coordinates the filing and maintenance of plant patent, plant breeders’ rights (PBRs), and plant-related trademark rights worldwide, and we have extensive experience preparing and obtaining utility patents for edited and transgenic plants expressing new traits, utility patents for new plant varieties, plant patents, and Plant Variety Protection (PVP) Certificates. We also advise and counsel clients on the handling of trademarks and variety denominations, and complex litigation matters.

In addition, we help our food and agtech clients in the U.S. and around the world secure patents on technologies related to artificial intelligence (AI), automation, biological pesticides, computer learning, data aggregation, drones, new plant traits, plant genomics, and user interfaces.

Life sciences data analytics are at the intersection of technology and healthcare, and our team advises clients on all legal aspects of this business, including patenting software and AI-related life sciences inventions, licensing of data, providing counsel on the steps to ensure data privacy and ethical use of data, and guiding clients through the FDA approval process for data-driven diagnostic assays and medical devices. Working at the forefront of both the life sciences and technology industries, we understand the challenges in patenting innovation in this evolving area and how to navigate the IP and regulatory hurdles in bringing new products to market.

Artificial Intelligence + Robotics
Morrison & Foerster provides sophisticated, full-service representation to a wide range of clients with companies that both develop and use cutting-edge, rapidly changing technology in the AI and robotics space. Our clients span the spectrum from startups to Silicon Valley industry leaders to global Fortune 100 power players. We work with clients from the earliest stages of development to protect innovations and obtain patent coverage for mechanical devices and robotics, artificial intelligence algorithms, virtual and augmented reality, drone technologies, automation, computer learning, graphics processing, and user interfaces.